Clinical Trials
5 trialsNCT05488314 2026-06-05
METalmark
Janssen Research & Development, LLC
Phase 1/2 Active not recruiting
NCT05908734 2026-06-05
PolyDamas
Janssen Research & Development, LLC
Phase 1/2 Active not recruiting
NCT06532032 2026-04-13
swalloWTail
Janssen Research & Development, LLC
Phase 1/2 Active not recruiting
NCT06083857 2026-03-11
PhI/II Study of Amivantamab and Tepotinib Combo in MET-altered Non-small Cell Lung Cancer
M.D. Anderson Cancer Center
Phase 1/2 Active not recruiting
NCT05845671 2026-01-14
Amivantamab With Tyrosine Kinase Inhibitors (TKI) for Advanced NSCLC With ALK, ROS1, or RET Alterations
University of Colorado, Denver
Phase 1/2 Active not recruiting